Suppr超能文献

在小鼠牛奶过敏模型中使用不可消化寡糖的口服免疫疗法疗效增强:Foxp3 + 调节性T细胞的潜在作用

Improved Efficacy of Oral Immunotherapy Using Non-Digestible Oligosaccharides in a Murine Cow's Milk Allergy Model: A Potential Role for Foxp3+ Regulatory T Cells.

作者信息

Vonk Marlotte M, Diks Mara A P, Wagenaar Laura, Smit Joost J, Pieters Raymond H H, Garssen Johan, van Esch Betty C A M, Knippels Léon M J

机构信息

Faculty of Science, Department of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.

Immunology Platform, Nutricia Research, Utrecht, Netherlands.

出版信息

Front Immunol. 2017 Sep 29;8:1230. doi: 10.3389/fimmu.2017.01230. eCollection 2017.

Abstract

BACKGROUND

Oral immunotherapy (OIT) is a promising therapeutic approach to treat food allergic patients. However, there are some concerns regarding its safety and long-term efficacy. The use of non-digestible oligosaccharides might improve OIT efficacy since they are known to directly modulate intestinal epithelial and immune cells in addition to acting as prebiotics.

AIM

To investigate whether a diet supplemented with plant-derived fructo-oligosaccharides (FOS) supports the efficacy of OIT in a murine cow's milk allergy model and to elucidate the potential mechanisms involved.

METHODS

After oral sensitization to the cow's milk protein whey, female C3H/HeOuJ mice were fed either a control diet or a diet supplemented with FOS (1% w/w) and received OIT (10 mg whey) 5 days a week for 3 weeks by gavage. Intradermal (i.d.) and intragastric (i.g.) challenges were performed to measure acute allergic symptoms and mast cell degranulation. Blood and organs were collected to measure antibody levels and T cell and dendritic cell populations. Spleen-derived T cell fractions (whole spleen- and CD25-depleted) were transferred to naïve recipient mice to confirm the involvement of regulatory T cells (Tregs) in allergy protection induced by OIT + FOS.

RESULTS

OIT + FOS decreased acute allergic symptoms and mast cell degranulation upon challenge and prevented the challenge-induced increase in whey-specific IgE as observed in sensitized mice. Early induction of Tregs in the mesenteric lymph nodes (MLN) of OIT + FOS mice coincided with reduced T cell responsiveness in splenocyte cultures. CD25 depletion in OIT + FOS-derived splenocyte suspensions prior to transfer abolished protection against signs of anaphylaxis in recipients. OIT + FOS increased serum galectin-9 levels. No differences in short-chain fatty acid (SCFA) levels in the cecum were observed between the treatment groups. Concisely, FOS supplementation significantly improved OIT in the acute allergic skin response, %Foxp3+ Tregs and %LAP+ Th3 cells in MLN, and serum galectin-9 levels.

CONCLUSION

FOS supplementation improved the efficacy of OIT in cow's milk allergic mice. Increased levels of Tregs in the MLN and abolished protection against signs of anaphylaxis upon transfer of CD25-depleted cell fractions, suggest a role for Foxp3+ Tregs in the protective effect of OIT + FOS.

摘要

背景

口服免疫疗法(OIT)是一种治疗食物过敏患者的有前景的治疗方法。然而,人们对其安全性和长期疗效存在一些担忧。使用不可消化的低聚糖可能会提高OIT的疗效,因为它们除了作为益生元外,还已知能直接调节肠道上皮细胞和免疫细胞。

目的

研究补充植物来源的低聚果糖(FOS)的饮食是否能支持OIT在小鼠牛奶过敏模型中的疗效,并阐明其中涉及的潜在机制。

方法

对牛奶蛋白乳清进行口服致敏后,给雌性C3H/HeOuJ小鼠喂食对照饮食或补充FOS(1% w/w)的饮食,并通过灌胃每周5天给予OIT(10mg乳清),持续3周。进行皮内(i.d.)和胃内(i.g.)激发试验以测量急性过敏症状和肥大细胞脱颗粒。收集血液和器官以测量抗体水平以及T细胞和树突状细胞群体。将脾脏来源的T细胞组分(全脾和去除CD25的)转移到未致敏的受体小鼠中,以确认调节性T细胞(Tregs)参与OIT + FOS诱导的过敏保护作用。

结果

OIT + FOS减轻了激发后的急性过敏症状和肥大细胞脱颗粒,并防止了激发诱导的致敏小鼠中乳清特异性IgE的增加。OIT + FOS小鼠肠系膜淋巴结(MLN)中Tregs的早期诱导与脾细胞培养中T细胞反应性的降低相一致。转移前OIT + FOS来源的脾细胞悬液中的CD25去除消除了对受体过敏反应迹象的保护作用。OIT + FOS增加了血清半乳糖凝集素-9水平。各治疗组之间盲肠中短链脂肪酸(SCFA)水平没有差异。简而言之,补充FOS显著改善了OIT在急性过敏皮肤反应、MLN中%Foxp3 + Tregs和%LAP + Th3细胞以及血清半乳糖凝集素-9水平方面的效果。

结论

补充FOS提高了OIT在牛奶过敏小鼠中的疗效。MLN中Tregs水平的增加以及去除CD25的细胞组分转移后对过敏反应迹象的保护作用消失,表明Foxp3 + Tregs在OIT + FOS的保护作用中发挥了作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/708f/5626810/edb2dae8f8ba/fimmu-08-01230-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验